Sunday, August 17, 2025 8/17/2025

Enhancing Rigor and Reproducibility of Translational Nonhuman Primate Models for Genetic and Regenerative Therapies

Award Number: R01OD036239
ORGANIZATION: OFFICE OF THE DIRECTOR, NIH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2024
PERIOD OF PERFORMANCE END DATE: 06/30/2029

Group Awards By:

View Award Description

Enhancing Rigor and Reproducibility of Translational Nonhuman Primate Models for Genetic and Regenerative Therapies - This application is submitted in response to PAR-23-040 with the goal of integrating cutting-edge in vivo imaging technologies and key immunologic assessments to enhance the rigor and reproducibility of translational nonhuman primate models for genetic and regenerative therapies. The proposal meets the objective of PAR-23-040, which is focused on “…developing and implementing broadly applicable technologies, tools, and resources for...enhancing rigor, reproducibility, and translatability of animal research”. We will support translational research by incorporating total-body positron emission tomography (PET) and correlative assessments of the immune system. The investigations proposed will enhance the rhesus monkey model system by creating or improving study protocols that provide a high level of sensitivity and reproducibility for assessments that are important to clinical translation. The Specific Aims are: (1) Use total-body PET imaging to longitudinally monitor gene transfer and biodistribution in preclinical studies of fetal or juvenile rhesus monkeys for clinical translation, and (2) Explore new readouts of immune responses to innovative therapeutics in tissue sites using T-cell tracking in translational nonhuman primate studies. These investigations will address relationships between local T-cell infiltration and circulating immunophenotypes with correlative in vivo imaging, which will enhance models and provide new methods to assess the primate immune system. Monitoring inflammation and immunity in targeted and non-targeted tissues is critically important to ensure safety as new therapeutics transition to the clinic for a range of common and rare diseases. These studies will provide predictive protocols and tools which will inform preclinical and IND- enabling studies for future human applications across age groups.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $781,525 )
2025	2025	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR STE 300	DAVIS	CA	95618	YOLO	USA	Research Infrastructure Programs	000	2	7/25/2025	NON-COMPETING CONTINUATION	$781,525
														Subtotal = $781,525

Issue Date FY: 2024 ( Subtotal = $781,525 )
2024	2024	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR STE 300	DAVIS	CA	95618	YOLO	USA	Research Infrastructure Programs	000	1	6/24/2024	NEW	$781,525
														Subtotal = $781,525

Grand Total All Awards = $1,563,050

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Enhancing Rigor and Reproducibility of Translational Nonhuman Primate Models for Genetic and Regenerative Therapies

Award Number: R01OD036239

ORGANIZATION: OFFICE OF THE DIRECTOR, NIH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2024

PERIOD OF PERFORMANCE END DATE: 06/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer